Free Trial

Baillie Gifford US Growth (LON:USA) Trading Down 0.2% - Time to Sell?

Baillie Gifford US Growth logo with Financial Services background

Baillie Gifford US Growth (LON:USA - Get Free Report) shares dropped 0.2% during trading on Thursday . The company traded as low as GBX 262 ($3.52) and last traded at GBX 263 ($3.53). Approximately 147,232 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 1,287,477 shares. The stock had previously closed at GBX 263.50 ($3.54).

Baillie Gifford US Growth Trading Up 1.0%

The firm has a market cap of £757.70 million and a PE ratio of 9.01. The business has a fifty day moving average price of GBX 246.54 and a 200 day moving average price of GBX 242.67.

About Baillie Gifford US Growth

(Get Free Report)

The Trust aims to produce long-term capital growth by investing predominantly in equities of companies which are incorporated, domiciled or conducting a significant portion of their business in the United States of America. The maximum amount which may be invested directly in private companies shall not exceed 50% of the total assets of the Company, measured at the time of investment.

Featured Stories

Should You Invest $1,000 in Baillie Gifford US Growth Right Now?

Before you consider Baillie Gifford US Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Baillie Gifford US Growth wasn't on the list.

While Baillie Gifford US Growth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines